Private health insurance coverage of drug use disorder treatment: 2005-2018.

Many privately insured adults with drug use disorders in the United States do not have health care coverage for drug use treatment. The Affordable Care Act sought to redress this gap by including substance use treatments as essential health benefits under new plans offered. This study used data from...

Full description

Bibliographic Details
Main Authors: Ramin Mojtabai, Christine Mauro, Melanie M Wall, Colleen L Barry, Mark Olfson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0240298
id doaj-14a4f25a2e324674a4b1165ef8bbf6ca
record_format Article
spelling doaj-14a4f25a2e324674a4b1165ef8bbf6ca2021-03-04T11:10:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011510e024029810.1371/journal.pone.0240298Private health insurance coverage of drug use disorder treatment: 2005-2018.Ramin MojtabaiChristine MauroMelanie M WallColleen L BarryMark OlfsonMany privately insured adults with drug use disorders in the United States do not have health care coverage for drug use treatment. The Affordable Care Act sought to redress this gap by including substance use treatments as essential health benefits under new plans offered. This study used data from 11,732 privately insured adult participants of the 2005-2018 National Survey on Drug Use and Health with drug use disorders to examine trends in drug use treatment coverage and the association of coverage with receiving treatment. 37.6% of the participants with drug use disorders did not know whether their plan covered drug use treatment, with little change over time. Among those who knew, coverage increased modestly between the 2005-2013 and 2014-2018 periods (73.5% vs. 77.5%, respectively, p = .015). Coverage was associated with receiving drug use treatment (adjusted odds ratio = 2.09, 95% confidence interval = 1.61-2.72, p < .001). However, even among participants with coverage, only 13.4% received treatment. Broader coverage of drug use treatment could potentially improve treatment rates.https://doi.org/10.1371/journal.pone.0240298
collection DOAJ
language English
format Article
sources DOAJ
author Ramin Mojtabai
Christine Mauro
Melanie M Wall
Colleen L Barry
Mark Olfson
spellingShingle Ramin Mojtabai
Christine Mauro
Melanie M Wall
Colleen L Barry
Mark Olfson
Private health insurance coverage of drug use disorder treatment: 2005-2018.
PLoS ONE
author_facet Ramin Mojtabai
Christine Mauro
Melanie M Wall
Colleen L Barry
Mark Olfson
author_sort Ramin Mojtabai
title Private health insurance coverage of drug use disorder treatment: 2005-2018.
title_short Private health insurance coverage of drug use disorder treatment: 2005-2018.
title_full Private health insurance coverage of drug use disorder treatment: 2005-2018.
title_fullStr Private health insurance coverage of drug use disorder treatment: 2005-2018.
title_full_unstemmed Private health insurance coverage of drug use disorder treatment: 2005-2018.
title_sort private health insurance coverage of drug use disorder treatment: 2005-2018.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Many privately insured adults with drug use disorders in the United States do not have health care coverage for drug use treatment. The Affordable Care Act sought to redress this gap by including substance use treatments as essential health benefits under new plans offered. This study used data from 11,732 privately insured adult participants of the 2005-2018 National Survey on Drug Use and Health with drug use disorders to examine trends in drug use treatment coverage and the association of coverage with receiving treatment. 37.6% of the participants with drug use disorders did not know whether their plan covered drug use treatment, with little change over time. Among those who knew, coverage increased modestly between the 2005-2013 and 2014-2018 periods (73.5% vs. 77.5%, respectively, p = .015). Coverage was associated with receiving drug use treatment (adjusted odds ratio = 2.09, 95% confidence interval = 1.61-2.72, p < .001). However, even among participants with coverage, only 13.4% received treatment. Broader coverage of drug use treatment could potentially improve treatment rates.
url https://doi.org/10.1371/journal.pone.0240298
work_keys_str_mv AT raminmojtabai privatehealthinsurancecoverageofdrugusedisordertreatment20052018
AT christinemauro privatehealthinsurancecoverageofdrugusedisordertreatment20052018
AT melaniemwall privatehealthinsurancecoverageofdrugusedisordertreatment20052018
AT colleenlbarry privatehealthinsurancecoverageofdrugusedisordertreatment20052018
AT markolfson privatehealthinsurancecoverageofdrugusedisordertreatment20052018
_version_ 1714804602542489600